Company · CIK 1872529
MDxHealth SA
| CIK | 1872529 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 8071 — Services-Medical Laboratories |
| Incorporated in | C9 |
| Business address | Belgium |
| Listed | MDXH (Nasdaq) |
| First annual or quarterly report | 2022-04-25 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292463 | 2025-12-29 | 2026-08-13 | 3 | |
| 333-268885 | 2022-12-19 | 2024-09-26 | 7 | |
| 333-280606 | 2024-06-28 | 2024-07-10 | 2 | |
| 333-260213 | 2021-10-13 | 2021-11-05 | 5 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-13 | 424B5Shelf takedown | 333-292463 | 0001213900-26-089071 |
| 2026-02-17 | EFFECTDeclared effective | 333-292463 | 9999999995-26-000606 |
| 2025-12-29 | F-3Shelf registered | 333-292463 | 0001213900-25-126084 |
| 2024-09-26 | 424B5Shelf takedown | 333-268885 | 0001213900-24-081940 |
| 2024-09-25 | 424B5Shelf takedown | 333-268885 | 0001213900-24-081808 |
| 2024-07-10 | EFFECTDeclared effective | 333-280606 | 9999999995-24-002118 |
| 2024-06-28 | F-3Shelf registered | 333-280606 | 0001213900-24-057313 |
| 2024-04-30 | 424B5Shelf takedown | 333-268885 | 0001213900-24-037945 |
| 2023-02-06 | 424B5Shelf takedown | 333-268885 | 0001213900-23-008482 |
| 2023-02-01 | 424B5Shelf takedown | 333-268885 | 0001213900-23-006694 |
| 2022-12-30 | EFFECTDeclared effective | 333-268885 | 9999999995-23-000009 |
| 2022-12-19 | F-3Shelf registered | 333-268885 | 0001213900-22-080993 |
| 2021-11-05 | 424B4Final prospectus | 333-260213 | 0001213900-21-057043 |
| 2021-11-03 | EFFECTDeclared effective | 333-260213 | 9999999995-21-004176 |
| 2021-11-01 | F-1/AAmendment | 333-260213 | 0001213900-21-055831 |
| 2021-10-28 | F-1/AAmendment | 333-260213 | 0001213900-21-054912 |
| 2021-10-13 | F-1Registration filed | 333-260213 | 0001213900-21-052578 |
| 2021-08-09 | DRSDraft made public | 377-05328 | 0001213900-21-041050 |